These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33549626)

  • 1. Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
    de Montmollin E; Faille D; Andrieu V; Ajzenberg N; Timsit JF
    J Infect; 2021 May; 82(5):e20-e22. PubMed ID: 33549626
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
    Ferrandis R; Llau JV; Quintana M; Sierra P; Hidalgo F; Cassinello C; Gómez-Luque A
    Crit Care; 2020 Jun; 24(1):332. PubMed ID: 32527286
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
    Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M
    Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis.
    Mumoli N; Conte G; Cei M; Vitale J; Capra R; Rotiroti G; Porta C; Monolo D; Colombo A; Mazzone A; Kucher N; Konstantinides SV; Dentali F; Barco S
    Thromb Res; 2021 Jul; 203():82-84. PubMed ID: 33975205
    [No Abstract]   [Full Text] [Related]  

  • 6. Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism.
    Haider Z; Rajalingam K; Khalid T; Oswal D; Dwarakanath A
    Eur J Intern Med; 2021 Jun; 88():141-143. PubMed ID: 33820684
    [No Abstract]   [Full Text] [Related]  

  • 7. Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19.
    Zermatten MG; Pantet O; Gomez F; Schneider A; Méan M; Mazzolai L; Hugli O; Bart PA; Papadimitriou-Olivgeris M; Alberio L;
    Thromb Res; 2020 Dec; 196():222-226. PubMed ID: 32916564
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
    Vazquez FJ; Korin J; Baldessari EM; Capparelli FJ; Gutierrez P; Pale C; Bocanegra F; Grand B; Penchasky D; Gonzalez Alcántara MM; Prémoli MS; Tabares A; Wainsztein N; Odetto D; Vaccaro C; Martínez Aquino E; Cumpian O; Falabella V; Antuel García S; Saadi J; Siccardi M; Gándara E
    Medicina (B Aires); 2020; 80 Suppl 3():65-66. PubMed ID: 32658849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in critically ill patients affected by ARDS related to COVID-19 in Northern-West Italy.
    Longhitano Y; Racca F; Zanza C; Piccioni A; Audo A; Muncinelli M; Santi R; Kozel D; Geraci C; Taverna M; Bonato V; Cassini F; Franceschi F
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9154-9160. PubMed ID: 32965007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).
    Linnemann B; Bauersachs R; Grebe M; Klamroth R; Müller O; Schellong S; Lichtenberg M
    Vasa; 2020 Jun; 49(4):259-263. PubMed ID: 32501145
    [No Abstract]   [Full Text] [Related]  

  • 11. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
    Eljilany I; Elzouki AN
    Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.
    Jonmarker S; Hollenberg J; Dahlberg M; Stackelberg O; Litorell J; Everhov ÅH; Järnbert-Pettersson H; Söderberg M; Grip J; Schandl A; Günther M; Cronhjort M
    Crit Care; 2020 Nov; 24(1):653. PubMed ID: 33225952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Need for Chemo-Thromboprophylaxis Protocols in Critically Ill COVID-19 Patients.
    Ehrlich H; McKenney M; Elkbuli A
    Am Surg; 2021 May; 87(5):698-699. PubMed ID: 33283541
    [No Abstract]   [Full Text] [Related]  

  • 14. An observational study of intermediate- or high-dose thromboprophylaxis for critically ill COVID-19 patients.
    Jonmarker S; Litorell J; Dahlberg M; Stackelberg O; Everhov ÅH; Söderberg M; Rubenson-Wahlin R; Günther M; Mårtensson J; Hollenberg J; Joelsson-Alm E; Cronhjort M
    Acta Anaesthesiol Scand; 2022 Mar; 66(3):365-374. PubMed ID: 34875111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous Thromboembolism Prophylaxis: A Narrative Review With a Focus on the High-Risk Critically Ill Patient.
    Lewis TC; Cortes J; Altshuler D; Papadopoulos J
    J Intensive Care Med; 2019; 34(11-12):877-888. PubMed ID: 30165770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era.
    MacDougall K; Spyropoulos AC
    Semin Respir Crit Care Med; 2021 Apr; 42(2):308-315. PubMed ID: 33548931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in non-critically ill patients with COVID-19 infection.
    Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O
    Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*.
    Lim W; Meade M; Lauzier F; Zarychanski R; Mehta S; Lamontagne F; Dodek P; McIntyre L; Hall R; Heels-Ansdell D; Fowler R; Pai M; Guyatt G; Crowther MA; Warkentin TE; Devereaux PJ; Walter SD; Muscedere J; Herridge M; Turgeon AF; Geerts W; Finfer S; Jacka M; Berwanger O; Ostermann M; Qushmaq I; Friedrich JO; Cook DJ;
    Crit Care Med; 2015 Feb; 43(2):401-10. PubMed ID: 25474533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey.
    Ferrandis R; Llau JV; Afshari A; Douketis JD; Gómez-Luque A; Samama CM
    Br J Anaesth; 2021 Oct; 127(4):e143-e145. PubMed ID: 34362558
    [No Abstract]   [Full Text] [Related]  

  • 20. Thromboprophylaxis Outcome in Childhood SARS-CoV-2 Infection: A Single-Center Experience.
    Karimi M; Sanaei Dashti A; Haghpanah S; Mansoori Y; Zarei T; Amanati A; Bordbar M
    J Pediatr Hematol Oncol; 2023 Jan; 45(1):e97-e102. PubMed ID: 36162044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.